{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:47:46Z","timestamp":1791982066758,"version":"4.4.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.spen.2026.101321","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:26:25Z","timestamp":1784010385000},"page":"101321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanisms and treatment of RSE: Of neurotransmission and neuroinflammation"],"prefix":"10.1016","volume":"59","author":[{"given":"Claudine","family":"Sculier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gaspard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Vezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 8","key":"10.1016\/j.spen.2026.101321_bib0001","first-page":"19\u201120","article-title":"Influence of brain development on status epilepticus","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.spen.2026.101321_bib0002","doi-asserted-by":"crossref","first-page":"380\u201191","DOI":"10.1038\/nrneurol.2009.80","article-title":"Epileptogenesis in the immature brain: emerging mechanisms","volume":"5","author":"Rakhade","year":"2009","journal-title":"Nat Rev Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.spen.2026.101321_bib0003","first-page":"155\u201169","article-title":"Long-term outcomes of status epilepticus: A critical assessment","volume":"59","author":"Sculier","year":"2018","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0004","doi-asserted-by":"crossref","first-page":"175\u201184","DOI":"10.1016\/j.siny.2013.02.003","article-title":"Mechanisms and effects of seizures in the immature brain","volume":"18","author":"Nardou","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0005","doi-asserted-by":"crossref","first-page":"12\u201130","DOI":"10.1111\/j.1528-1157.1997.tb01074.x","article-title":"Epilepsy in the developing brain: lessons from the laboratory and clinic","volume":"38","author":"Holmes","year":"1997","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.spen.2026.101321_bib0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/epi4.12271","article-title":"Treatment of early life status epilepticus: What can we learn from animal models?","volume":"3","author":"Thompson","year":"2018","journal-title":"Epilepsia Open"},{"issue":"10","key":"10.1016\/j.spen.2026.101321_bib0007","doi-asserted-by":"crossref","first-page":"1515\u201123","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013Report of the ILAE Task Force on classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.spen.2026.101321_bib0008","doi-asserted-by":"crossref","first-page":"2980\u201194","DOI":"10.1111\/epi.18398","article-title":"Synaptic inhibitory dynamics drive benzodiazepine response in pediatric status epilepticus","volume":"66","author":"Fedele","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101321_bib0009","doi-asserted-by":"crossref","first-page":"33\u201141","DOI":"10.1016\/j.pediatrneurol.2018.06.004","article-title":"Hospital emergency treatment of convulsive status epilepticus: comparison of pathways from ten pediatric research centers","volume":"86","author":"Vasquez","year":"2018","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2026.101321_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1175370","article-title":"Treatment of pediatric convulsive status epilepticus","volume":"14","author":"Becker","year":"2023","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0011","doi-asserted-by":"crossref","first-page":"739\u201144","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"issue":"9531","key":"10.1016\/j.spen.2026.101321_bib0012","doi-asserted-by":"crossref","first-page":"222\u20119","DOI":"10.1016\/S0140-6736(06)69043-0","article-title":"Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study","volume":"368","author":"Chin","year":"2006","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.spen.2026.101321_bib0013","doi-asserted-by":"crossref","first-page":"1316\u20118","DOI":"10.1212\/01.wnl.0000180959.31355.92","article-title":"Treatment delay and the risk of prolonged status epilepticus","volume":"65","author":"Eriksson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2026.101321_bib0014","doi-asserted-by":"crossref","first-page":"62\u201171","DOI":"10.1016\/j.seizure.2018.05.012","article-title":"Pediatric refractory and super-refractory status epilepticus","volume":"68","author":"Vasquez","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2026.101321_bib0015","doi-asserted-by":"crossref","first-page":"62\u201171","DOI":"10.1016\/j.seizure.2018.05.012","article-title":"Pediatric refractory and super-refractory status epilepticus","volume":"68","author":"Vasquez","year":"2019","journal-title":"Seizure"},{"issue":"3 Epilepsy","key":"10.1016\/j.spen.2026.101321_bib0016","first-page":"767\u201194","volume":"19","author":"Hirsch","year":"2013","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0017","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00004691-199512040-00004","article-title":"Pathophysiology of status epilepticus","volume":"12","author":"Fountain","year":"1995","journal-title":"J Clin Neurophysiol"},{"issue":"s1","key":"10.1016\/j.spen.2026.101321_bib0018","doi-asserted-by":"crossref","first-page":"S54\u20118","DOI":"10.1111\/j.1528-1157.1993.tb05906.x","article-title":"Systemic effects of generalized convulsive status epilepticus","volume":"34","author":"Walton","year":"1993","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0019","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/CCM.0000000000002843","article-title":"Acute systemic complications of convulsive status epilepticus\u2014A systematic review","volume":"46","author":"Sutter","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.spen.2026.101321_bib0020","doi-asserted-by":"crossref","first-page":"16\u201121","DOI":"10.1016\/j.seizure.2018.08.002","article-title":"Pathophysiology of convulsive status epilepticus","volume":"68","author":"S\u00e1nchez Fern\u00e1ndez","year":"2019","journal-title":"Seizure"},{"issue":"Pt 11","key":"10.1016\/j.spen.2026.101321_bib0021","first-page":"2551\u20117","article-title":"Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study","volume":"126","author":"Scott","year":"2003","journal-title":"Brain J Neurol"},{"issue":"3","key":"10.1016\/j.spen.2026.101321_bib0022","first-page":"193\u2011200","article-title":"Hippocampal sclerosis: causes and prevention","volume":"35","author":"Walker","year":"2015","journal-title":"Semin Neurol"},{"issue":"8","key":"10.1016\/j.spen.2026.101321_bib0023","doi-asserted-by":"crossref","first-page":"1316\u20118","DOI":"10.1212\/01.wnl.0000180959.31355.92","article-title":"Treatment delay and the risk of prolonged status epilepticus","volume":"65","author":"Eriksson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2026.101321_bib0024","doi-asserted-by":"crossref","first-page":"113\u20118","DOI":"10.1016\/j.pediatrneurol.2024.04.021","article-title":"Investigating associations between nonadherence to guideline-recommended treatment of pediatric seizures and adverse outcomes: A Canadian feasibility study","volume":"156","author":"Moreau","year":"2024","journal-title":"Pediatr Neurol"},{"issue":"9","key":"10.1016\/j.spen.2026.101321_bib0025","doi-asserted-by":"crossref","first-page":"3193\u2011206","DOI":"10.1111\/epi.18455","article-title":"Optimizing pediatric status epilepticus management: the role of early midazolam infusion and adherence to clinical practice guidelines","volume":"66","author":"Rosati","year":"2025","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0026","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s43141-021-00224-0","article-title":"GABAA receptors: structure, function, pharmacology, and related disorders","volume":"19","author":"Ghit","year":"2021","journal-title":"J Genet Eng Biotechnol"},{"issue":"23","key":"10.1016\/j.spen.2026.101321_bib0027","doi-asserted-by":"crossref","first-page":"5511\u201120","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"34","key":"10.1016\/j.spen.2026.101321_bib0028","doi-asserted-by":"crossref","first-page":"7724\u201133","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"1\u20112","key":"10.1016\/j.spen.2026.101321_bib0029","first-page":"179\u201185","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0030","doi-asserted-by":"crossref","first-page":"410\u20118","DOI":"10.1001\/jamaneurol.2017.4382","article-title":"Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus","volume":"75","author":"Ga\u00ednza-Lein","year":"2018","journal-title":"JAMA Neurol"},{"issue":"34","key":"10.1016\/j.spen.2026.101321_bib0031","doi-asserted-by":"crossref","first-page":"7724\u201133","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"2","key":"10.1016\/j.spen.2026.101321_bib0032","doi-asserted-by":"crossref","first-page":"376\u201184","DOI":"10.1523\/JNEUROSCI.4346-07.2008","article-title":"Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus","volume":"28","author":"Terunuma","year":"2008","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"6","key":"10.1016\/j.spen.2026.101321_bib0033","doi-asserted-by":"crossref","first-page":"411\u20114","DOI":"10.1002\/acn3.408","article-title":"First-in-man allopregnanolone use in super-refractory status epilepticus","volume":"4","author":"Vaitkevicius","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.spen.2026.101321_bib0034","article-title":"Intravenous ganaxolone in pediatric super-refractory status epilepticus: A single hospital experience","volume":"20","author":"Singh","year":"2022","journal-title":"Epilepsy Behav Rep"},{"issue":"9","key":"10.1016\/j.spen.2026.101321_bib0035","doi-asserted-by":"crossref","first-page":"2381\u201191","DOI":"10.1111\/epi.17343","article-title":"Intravenous ganaxolone for the treatment of refractory status epilepticus: results from an open-label, dose-finding, phase 2 trial","volume":"63","author":"Vaitkevicius","year":"2022","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.spen.2026.101321_bib0036","doi-asserted-by":"crossref","first-page":"1355\u201165","DOI":"10.1111\/epi.13098","article-title":"Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal","volume":"56","author":"Joshi","year":"2015","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.spen.2026.101321_bib0037","doi-asserted-by":"crossref","first-page":"3482\u2011501","DOI":"10.1093\/brain\/awz283","article-title":"Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticus","volume":"142","author":"Burman","year":"2019","journal-title":"Brain J Neurol"},{"issue":"9","key":"10.1016\/j.spen.2026.101321_bib0038","doi-asserted-by":"crossref","first-page":"1570\u20118","DOI":"10.1111\/j.1528-1167.2011.03247.x","article-title":"Positive shifts of the GABAA receptor reversal potential due to altered chloride homeostasis is widespread after status epilepticus","volume":"52","author":"Barmashenko","year":"2011","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.spen.2026.101321_bib0039","doi-asserted-by":"crossref","first-page":"3523\u20118","DOI":"10.1073\/pnas.1415126112","article-title":"KCC2 activity is critical in limiting the onset and severity of status epilepticus","volume":"112","author":"Silayeva","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.spen.2026.101321_bib0040","doi-asserted-by":"crossref","first-page":"222\u201132","DOI":"10.1111\/epi.13270","article-title":"Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus","volume":"57","author":"Sivakumaran","year":"2016","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.spen.2026.101321_bib0041","article-title":"Direct activation of KCC2 arrests benzodiazepine refractory status epilepticus and limits the subsequent neuronal injury in mice","volume":"4","author":"Jarvis","year":"2023","journal-title":"Cell Rep Med"},{"issue":"40","key":"10.1016\/j.spen.2026.101321_bib0042","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1810134115","article-title":"Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures","volume":"115","author":"Moore","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spen.2026.101321_bib0043","doi-asserted-by":"crossref","first-page":"225\u201138","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"Suppl 6","key":"10.1016\/j.spen.2026.101321_bib0044","first-page":"14\u20116","article-title":"Receptor trafficking hypothesis revisited: plasticity of AMPA receptors during established status epilepticus","volume":"54","author":"Rajasekaran","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0045","doi-asserted-by":"crossref","first-page":"91\u2011102","DOI":"10.1002\/ana.23570","article-title":"Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus","volume":"72","author":"Rajasekaran","year":"2012","journal-title":"Ann Neurol"},{"issue":"S1","key":"10.1016\/j.spen.2026.101321_bib0046","doi-asserted-by":"crossref","first-page":"S35\u201165","DOI":"10.1002\/epi4.12718","article-title":"In the fast lane: receptor trafficking during status epilepticus","volume":"8","author":"Naylor","year":"2023","journal-title":"Epilepsia Open"},{"issue":"2\u20113","key":"10.1016\/j.spen.2026.101321_bib0047","first-page":"117\u201122","article-title":"Ketamine controls prolonged status epilepticus","volume":"42","author":"Borris","year":"2000","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.spen.2026.101321_bib0048","doi-asserted-by":"crossref","first-page":"301\u201112","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res"},{"issue":"19","key":"10.1016\/j.spen.2026.101321_bib0049","doi-asserted-by":"crossref","first-page":"7532\u201140","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"Suppl 12","key":"10.1016\/j.spen.2026.101321_bib0050","first-page":"16\u20118","article-title":"Molecular basis of self-sustaining seizures and pharmacoresistance during status epilepticus: the receptor trafficking hypothesis revisited","volume":"50","author":"Wasterlain","year":"2009","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.spen.2026.101321_bib0051","doi-asserted-by":"crossref","first-page":"3482\u2011501","DOI":"10.1093\/brain\/awz283","article-title":"Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticus","volume":"142","author":"Burman","year":"2019","journal-title":"Brain J Neurol"},{"issue":"1\u20112","key":"10.1016\/j.spen.2026.101321_bib0052","first-page":"179\u201185","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res"},{"issue":"11","key":"10.1016\/j.spen.2026.101321_bib0053","doi-asserted-by":"crossref","first-page":"1205\u201113","DOI":"10.1038\/nm1301","article-title":"NKCC1 transporter facilitates seizures in the developing brain","volume":"11","author":"Dzhala","year":"2005","journal-title":"Nat Med"},{"issue":"35","key":"10.1016\/j.spen.2026.101321_bib0054","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1769-10.2010","article-title":"Progressive NKCC1-dependent neuronal chloride accumulation during neonatal seizures","volume":"30","author":"Dzhala","year":"2010","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0055","first-page":"254\u201160","article-title":"Role of excitatory amino acids in developmental epilepsies","volume":"7","author":"Raol","year":"2001","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0056","doi-asserted-by":"crossref","first-page":"745\u201152","DOI":"10.1111\/epi.14022","article-title":"New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives","volume":"59","author":"Gaspard","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101321_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109095","article-title":"Neuroimmunology of status epilepticus","volume":"140","author":"Vezzani","year":"2023","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.spen.2026.101321_bib0058","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022699","article-title":"Immunity and inflammation in epilepsy","volume":"6","author":"Vezzani","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"10.1016\/j.spen.2026.101321_bib0059","doi-asserted-by":"crossref","first-page":"707\u201122","DOI":"10.1038\/s41582-022-00727-5","article-title":"Astrocytes in the initiation and progression of epilepsy","volume":"18","author":"Vezzani","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.spen.2026.101321_bib0060","doi-asserted-by":"crossref","first-page":"1281\u20119","DOI":"10.1016\/j.bbi.2011.03.018","article-title":"IL-1 receptor\/toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures","volume":"25","author":"Vezzani","year":"2011","journal-title":"Brain Behav Immun"},{"issue":"Pt A","key":"10.1016\/j.spen.2026.101321_bib0061","first-page":"70\u201182","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.spen.2026.101321_bib0062","doi-asserted-by":"crossref","first-page":"3688\u2011702","DOI":"10.1007\/s00415-023-11726-x","article-title":"Neuropathology of new-onset refractory status epilepticus (NORSE)","volume":"270","author":"Hanin","year":"2023","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.spen.2026.101321_bib0063","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2013.3.FOCUS1336","article-title":"Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus","volume":"34","author":"Juh\u00e1sz","year":"2013","journal-title":"Neurosurg Focus"},{"issue":"7","key":"10.1016\/j.spen.2026.101321_bib0064","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1093\/brain\/awz130","article-title":"Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy","volume":"142","author":"Pauletti","year":"2019","journal-title":"Brain J Neurol"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0065","doi-asserted-by":"crossref","first-page":"75\u201190","DOI":"10.1002\/ana.26627","article-title":"Cytokines in new-onset refractory status epilepticus predict outcomes","volume":"94","author":"Hanin","year":"2023","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0066","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200403","article-title":"Identification of distinct biological groups of patients with cryptogenic NORSE via inflammatory profiling","volume":"12","author":"Guillemaud","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0067","doi-asserted-by":"crossref","first-page":"116\u201125","DOI":"10.1016\/j.yfrne.2011.12.002","article-title":"Cytokines and brain excitability","volume":"33","author":"Galic","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.spen.2026.101321_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106027","article-title":"Neuroinflammation microenvironment sharpens seizure circuit","volume":"178","author":"Villasana-Salazar","year":"2023","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.spen.2026.101321_bib0069","doi-asserted-by":"crossref","first-page":"1203\u201123","DOI":"10.1111\/epi.17933","article-title":"Second-line immunotherapy in new onset refractory status epilepticus","volume":"65","author":"Hanin","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101321_bib0070","doi-asserted-by":"crossref","first-page":"267\u201171","DOI":"10.1016\/j.expneurol.2013.05.010","article-title":"The dual role of TNF-\u03b1 and its receptors in seizures","volume":"247","author":"Balosso","year":"2013","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0071","doi-asserted-by":"crossref","first-page":"301\u20118","DOI":"10.1016\/j.neuroscience.2005.07.063","article-title":"Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system","volume":"137","author":"Ravizza","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.spen.2026.101321_bib0072","doi-asserted-by":"crossref","first-page":"329\u201148","DOI":"10.1016\/S0306-4522(03)00593-1","article-title":"Spatiotemporal distribution of gp130 cytokines and their receptors after status epilepticus: comparison with neuronal degeneration and microglial activation","volume":"122","author":"Rosell","year":"2003","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.spen.2026.101321_bib0073","doi-asserted-by":"crossref","first-page":"7500\u201111","DOI":"10.1007\/s12035-018-0915-1","article-title":"Neuroinflammation alters integrative properties of rat hippocampal pyramidal cells","volume":"55","author":"Frigerio","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0074","doi-asserted-by":"crossref","first-page":"26\u201136","DOI":"10.1016\/j.nbd.2008.06.013","article-title":"Mislocalization of h channel subunits underlies h channelopathy in temporal lobe epilepsy","volume":"32","author":"Shin","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.spen.2026.101321_bib0075","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022384","article-title":"Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in epilepsy","volume":"6","author":"Brennan","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0076","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1038\/s41598-017-09182-5","article-title":"Inflammatory cytokine-induced changes in neural network activity measured by waveform analysis of high-content calcium imaging in murine cortical neurons","volume":"7","author":"Clarkson","year":"2017","journal-title":"Sci Rep"},{"issue":"Pt 9","key":"10.1016\/j.spen.2026.101321_bib0077","first-page":"2478\u201186","article-title":"The cortical innate immune response increases local neuronal excitability leading to seizures","volume":"132","author":"Rodgers","year":"2009","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.spen.2026.101321_bib0078","first-page":"1489\u201195","article-title":"Acute lipopolysaccharide exposure facilitates epileptiform activity via enhanced excitatory synaptic transmission and neuronal excitability in vitro","volume":"10","author":"Gao","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.spen.2026.101321_bib0079","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/neuro.08.014.2009","article-title":"Early-life programming of later-life brain and behavior: a critical role for the immune system","volume":"3","author":"Bilbo","year":"2009","journal-title":"Front Behav Neurosci"},{"issue":"25","key":"10.1016\/j.spen.2026.101321_bib0080","doi-asserted-by":"crossref","first-page":"8692\u2011700","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","article-title":"Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases","volume":"23","author":"Viviani","year":"2003","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"Pt 12","key":"10.1016\/j.spen.2026.101321_bib0081","first-page":"3256\u201165","article-title":"A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta","volume":"131","author":"Balosso","year":"2008","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.spen.2026.101321_bib0082","doi-asserted-by":"crossref","first-page":"311\u201120","DOI":"10.1016\/j.nbd.2015.07.003","article-title":"GABAA currents are decreased by IL-1\u03b2 in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis","volume":"82","author":"Roseti","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.spen.2026.101321_bib0083","doi-asserted-by":"crossref","first-page":"574\u201182","DOI":"10.1016\/j.biopsych.2011.11.018","article-title":"The stress-induced cytokine interleukin-6 decreases the inhibition\/excitation ratio in the rat temporal cortex via trans-signaling","volume":"71","author":"Garcia-Oscos","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.spen.2026.101321_bib0084","doi-asserted-by":"crossref","first-page":"3219\u201128","DOI":"10.1523\/JNEUROSCI.4486-04.2005","article-title":"Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha","volume":"25","author":"Stellwagen","year":"2005","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"10.1016\/j.spen.2026.101321_bib0085","doi-asserted-by":"crossref","first-page":"429\u201137","DOI":"10.1016\/j.expneurol.2013.01.011","article-title":"Opposing actions of hippocampus tnf\u03b1 receptors on limbic seizure susceptibility","volume":"247","author":"Weinberg","year":"2013","journal-title":"Exp Neurol"},{"issue":"6","key":"10.1016\/j.spen.2026.101321_bib0086","doi-asserted-by":"crossref","first-page":"804\u201112","DOI":"10.1002\/ana.20480","article-title":"Tumor necrosis factor-\u03b1 inhibits seizures in mice via p75 receptors","volume":"57","author":"Balosso","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2026.101321_bib0087","doi-asserted-by":"crossref","first-page":"1\u201116","DOI":"10.1016\/j.neuroscience.2020.06.024","article-title":"Loss of protection by antiepileptic drugs in lipopolysaccharide-primed pilocarpine-induced status epilepticus is mediated via inflammatory signalling","volume":"442","author":"Vyas","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.spen.2026.101321_bib0088","doi-asserted-by":"crossref","first-page":"22\u20119","DOI":"10.1016\/j.neuroscience.2016.04.036","article-title":"Interleukin-1 receptor is a target for adjunctive control of diazepam-refractory status epilepticus in mice","volume":"328","author":"Xu","year":"2016","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.spen.2026.101321_bib0089","doi-asserted-by":"crossref","first-page":"2986\u20113006","DOI":"10.1111\/bph.15785","article-title":"Increased expression of the ATP-gated P2X7 receptor reduces responsiveness to anti-convulsants during status epilepticus in mice","volume":"179","author":"Beamer","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1016\/j.spen.2026.101321_bib0090","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.3390\/cells9102176","article-title":"Neuron-Glia Interactions in Neurodevelopmental Disorders","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0091","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"issue":"5","key":"10.1016\/j.spen.2026.101321_bib0092","doi-asserted-by":"crossref","first-page":"534\u201148","DOI":"10.1001\/jamaneurol.2024.0108","article-title":"Treatment of refractory status epilepticus with continuous intravenous anesthetic drugs: A systematic review","volume":"81","author":"Au","year":"2024","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0093","doi-asserted-by":"crossref","first-page":"4\u201110","DOI":"10.1007\/s12028-010-9445-z","article-title":"A randomized trial for the treatment of refractory status epilepticus","volume":"14","author":"Rossetti","year":"2011","journal-title":"Neurocrit Care"},{"issue":"2","key":"10.1016\/j.spen.2026.101321_bib0094","first-page":"74\u20119","article-title":"The efficacy of propofol and Midazolam in treatment of refractory status epilepticus in children","volume":"32","author":"Mahvelati","year":"2007","journal-title":"Iran J Med Sci"},{"issue":"6","key":"10.1016\/j.spen.2026.101321_bib0095","first-page":"441\u20118","article-title":"A comparative study of Midazolam and target-controlled propofol infusion in the treatment of refractory status epilepticus","volume":"22","author":"Masapu","year":"2018","journal-title":"Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med"},{"issue":"11","key":"10.1016\/j.spen.2026.101321_bib0096","doi-asserted-by":"crossref","first-page":"997\u20111009","DOI":"10.1007\/s40263-018-0569-6","article-title":"Ketamine for refractory status epilepticus: A systematic review","volume":"32","author":"Rosati","year":"2018","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0097","doi-asserted-by":"crossref","first-page":"799\u2011806","DOI":"10.1007\/s00415-016-8074-7","article-title":"Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety","volume":"263","author":"Bellante","year":"2016","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.spen.2026.101321_bib0098","first-page":"968\u201175","article-title":"Refractory status epilepticus in children: intention to treat with continuous infusions of Midazolam and Pentobarbital","volume":"17","author":"Tasker","year":"2016","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0099","doi-asserted-by":"crossref","first-page":"359\u201165","DOI":"10.1212\/WNL.0000000000000054","article-title":"High-dose midazolam infusion for refractory status epilepticus","volume":"82","author":"Fernandez","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0100","first-page":"51\u20115","article-title":"Akhondi-Asl A. Pharmacokinetic modeling of optimized midazolam and pentobarbital dosing used in treatment protocols of refractory status epilepticus","volume":"24","author":"Luchette","year":"2023","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"issue":"12","key":"10.1016\/j.spen.2026.101321_bib0101","doi-asserted-by":"crossref","first-page":"e1227\u201138","DOI":"10.1212\/WNL.0000000000200889","article-title":"Ketamine for management of neonatal and pediatric refractory status epilepticus","volume":"99","author":"Jacobwitz","year":"2022","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.spen.2026.101321_bib0102","doi-asserted-by":"crossref","first-page":"2355\u20118","DOI":"10.1212\/WNL.0b013e318278b685","article-title":"Efficacy and safety of ketamine in refractory status epilepticus in children","volume":"79","author":"Rosati","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.spen.2026.101321_bib0103","doi-asserted-by":"crossref","first-page":"984\u201195","DOI":"10.1007\/s12028-023-01859-2","article-title":"A comparison of ketamine and Midazolam as first-line anesthetic infusions for pediatric status epilepticus","volume":"40","author":"Jacobwitz","year":"2024","journal-title":"Neurocrit Care"},{"issue":"5","key":"10.1016\/j.spen.2026.101321_bib0104","doi-asserted-by":"crossref","first-page":"245\u201164","DOI":"10.1177\/1535759720928269","article-title":"Treatment of refractory convulsive status epilepticus: a comprehensive review by the american epilepsy society treatments committee","volume":"20","author":"Vossler","year":"2020","journal-title":"Epilepsy Curr."},{"issue":"2","key":"10.1016\/j.spen.2026.101321_bib0105","doi-asserted-by":"crossref","first-page":"193\u2011200","DOI":"10.1007\/s12028-012-9790-1","article-title":"Treatment of status epilepticus: an international survey of experts","volume":"18","author":"Riviello","year":"2013","journal-title":"Neurocrit Care"},{"issue":"5","key":"10.1016\/j.spen.2026.101321_bib0106","doi-asserted-by":"crossref","first-page":"921\u201134","DOI":"10.1111\/epi.14706","article-title":"Duration of therapeutic coma and outcome of refractory status epilepticus","volume":"60","author":"Muhlhofer","year":"2019","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.spen.2026.101321_bib0107","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200550","article-title":"Modified 2HELPS2B score predicts failure to wean from anesthetics in refractory and super-refractory status epilepticus","volume":"15","author":"Matteo","year":"2025","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"10.1016\/j.spen.2026.101321_bib0108","doi-asserted-by":"crossref","first-page":"407\u201114","DOI":"10.1007\/s12028-016-0294-2","article-title":"Ritzl EK. EEG characteristics of successful burst suppression for refractory status epilepticus","volume":"25","author":"Johnson","year":"2016","journal-title":"Neurocrit Care"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0109","first-page":"66\u201171","article-title":"Highly epileptiform bursts are associated with seizure recurrence","volume":"33","author":"Thompson","year":"2016","journal-title":"J Clin Neurophysiol Off Publ Am Electroencephalogr Soc"},{"key":"10.1016\/j.spen.2026.101321_bib0110","doi-asserted-by":"crossref","first-page":"98\u2011105","DOI":"10.1016\/j.clinph.2023.03.011","article-title":"Quantitative assessment of burst suppression as a predictor of seizure recurrence in refractory status epilepticus","volume":"150","author":"Fong","year":"2023","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0111","first-page":"1143\u201157","article-title":"Electrographic predictors of successful weaning from anaesthetics in refractory status epilepticus","volume":"143","author":"Rubin","year":"2020","journal-title":"Brain J Neurol"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0112","doi-asserted-by":"crossref","first-page":"1\u201116","DOI":"10.1007\/s00134-023-07263-w","article-title":"Status epilepticus in the ICU","volume":"50","author":"Rossetti","year":"2024","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.spen.2026.101321_bib0113","doi-asserted-by":"crossref","first-page":"e1191\u2011201","DOI":"10.1212\/WNL.0000000000200818","article-title":"Management of refractory status Epilepticus","volume":"99","author":"Chiu","year":"2022","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.spen.2026.101321_bib0114","doi-asserted-by":"crossref","first-page":"959\u201168","DOI":"10.1001\/jamaneurol.2023.2407","article-title":"Outcomes and treatment approaches for super-refractory status epilepticus: A systematic review and meta-analysis","volume":"80","author":"Cornwall","year":"2023","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.spen.2026.101321_bib0115","doi-asserted-by":"crossref","first-page":"559\u2011602","DOI":"10.1212\/CON.0000000000001103","article-title":"Management of status epilepticus, refractory status epilepticus, and super-refractory status epilepticus","volume":"28","author":"Trinka","year":"2022","journal-title":"Continuum"},{"key":"10.1016\/j.spen.2026.101321_bib0116","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1134827","article-title":"Ketogenic diet for super-refractory status epilepticus (SRSE) with NORSE and FIRES: single tertiary center experience and literature data","volume":"14","author":"Nabbout","year":"2023","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.spen.2026.101321_bib0117","doi-asserted-by":"crossref","first-page":"43\u201158","DOI":"10.1111\/j.1528-1167.2007.00915.x","article-title":"Anticonvulsant mechanisms of the ketogenic diet","volume":"48","author":"Bough","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101321_bib0118","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fnins.2019.00005","article-title":"Ketogenic diet and epilepsy: what we know so far","volume":"13","author":"D\u2019Andrea Meira","year":"2019","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.spen.2026.101321_bib0119","doi-asserted-by":"crossref","first-page":"473\u201188","DOI":"10.1515\/revneuro-2023-0128","article-title":"Inflammation and oxidative stress in epileptic children: from molecular mechanisms to clinical application of ketogenic diet","volume":"35","author":"Ildarabadi","year":"2024","journal-title":"Rev Neurosci"},{"issue":"3","key":"10.1016\/j.spen.2026.101321_bib0120","doi-asserted-by":"crossref","first-page":"263\u20119","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.spen.2026.101321_bib0121","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.04.027","article-title":"The gut microbiota mediates the anti-seizure effects of the ketogenic diet","volume":"173","author":"Olson","year":"2018","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.spen.2026.101321_bib0122","doi-asserted-by":"crossref","first-page":"3254\u201168","DOI":"10.1111\/epi.18450","article-title":"Patients with status epilepticus and new-onset refractory status epilepticus display drastically altered fecal microbiomes compared to chronic epilepsy patients","volume":"66","author":"Steriade","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2026.101321_bib0123","doi-asserted-by":"crossref","first-page":"62\u20115","DOI":"10.1016\/j.seizure.2016.07.006","article-title":"Ketogenic diet treatment for pediatric super-refractory status epilepticus","volume":"41","author":"Appavu","year":"2016","journal-title":"Seizure - Eur J Epilepsy"},{"key":"10.1016\/j.spen.2026.101321_bib0124","first-page":"242\u20118","article-title":"Ketogenic diet treatment of children in the intensive care unit: safety, tolerability, and effectiveness. Seizure","volume":"80","author":"Worden","year":"2020","journal-title":"Eur J Epilepsy"},{"issue":"2","key":"10.1016\/j.spen.2026.101321_bib0125","doi-asserted-by":"crossref","first-page":"110\u20116","DOI":"10.1097\/WCO.0000000000001137","article-title":"New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome","volume":"36","author":"Sculier","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2026.101321_bib0126","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.643105","article-title":"Dietary management of children with super-refractory status epilepticus: A systematic review and experience in a single UK tertiary centre","volume":"12","author":"Schoeler","year":"2021","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.spen.2026.101321_bib0127","doi-asserted-by":"crossref","first-page":"259\u201166","DOI":"10.1177\/0883073813516192","article-title":"The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: challenges in implementation in the pediatric and neonatal intensive care units","volume":"30","author":"Cobo","year":"2015","journal-title":"J Child Neurol"},{"issue":"11","key":"10.1016\/j.spen.2026.101321_bib0128","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1111\/epi.17397","article-title":"International consensus recommendations for management of New Onset Refractory Status Epilepticus (NORSE) incl. Febrile infection-related epilepsy syndrome (FIRES): Statements and supporting evidence","volume":"63","author":"Wickstrom","year":"2022","journal-title":"Epilepsia"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909126000653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909126000653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:06:23Z","timestamp":1791979583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909126000653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":128,"alternative-id":["S1071909126000653"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2026.101321","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and treatment of RSE: Of neurotransmission and neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2026.101321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101321"}}